Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18
Abstract To evaluate the clinical predictive value of serum alpha-fetoprotein variants (AFP-L2, AFP-L3) in combination with maternal serum prenatal screening biomarkers in predicting fetal trisomy 21 and trisomy 18. We analyze the data of singleton pregnant women at 15–20+6 weeks of 731,922 gravidas...
Main Authors: | Yiming Chen, Yijie Chen, Wenwen Ning, Wen Zhang, Liyao Li, Xiaoying Wang, Yixuan Yin, Huimin Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-16807-x |
Similar Items
-
Maternal prenatal screening programs that predict trisomy 21, trisomy 18, and neural tube defects in offspring.
by: Yiming Chen, et al.
Published: (2023-01-01) -
Maternal prenatal screening programs that predict trisomy 21, trisomy 18, and neural tube defects in offspring
by: Yiming Chen, et al.
Published: (2023-01-01) -
Analysis of Second Trimester Maternal Quadruple Screening Test for Trisomy 21 and Trisomy 18
by: Katja Bricelj, et al.
Published: (2014-10-01) -
New cut-off values for screening of trisomy 21, 18 and open neural tube defects (ONTD) during the second trimester in pregnant women with advanced maternal age
by: Yiming Chen, et al.
Published: (2020-12-01) -
Correlation between elevated maternal serum alpha-fetoprotein and ischemic placental disease: a retrospective cohort study
by: Xiaoqing Dai, et al.
Published: (2023-12-01)